@article{article, title  = {{UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.urolonc.2024.01.161 }},

 year = {{2024}},

 month = {{3}},

 author = {{Catto JWF and Hussain SA and Tran B and Pignot G and Master V and Rouprêt M and Tubaro A and Shimizu N and Vasdev N and Nishiyama H and Daneshmand S et al}},

 doi = {{10.1016/j.urolonc.2024.01.161}},

 volume = {{42}},

 journal = {{Urologic Oncology: Seminars and Original Investigations}},

 pages = {{S53-S53}},

 note = {{Accessed on 2024/10/23}}}